Supplementary Figure S1 from ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair
Abstract
Supplementary Figure S1. Representative phase-contrast images of neurospheres treated with 100 μM TMZ for 6 days.
Fields of Study & Subjects
Glioma Diagnosis and Treatment
PARP inhibition in cancer therapy
DNA Repair Mechanisms
Publication details
- Publication date
- 27 January 2026